Sfoglia per ???browse.type.metadata.subjectIsicrui???
Pharmacological characterization of adenosine receptors on isolated human bronchi
2011-12-01 Calzetta, L; Spina, D; Cazzola, M; Page, C; Facciolo, F; Rendina, E; Matera, M
Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi
2017-01-01 Calzetta, L; Rogliani, P; Mattei, M; Alfonsi, P; Cito, G; Pistocchini, E; Cazzola, M; Matera, Mg
Pharmacological characterization of the interaction between tiotropium bromide and olodaterol on human bronchi and small airways
2019-01-01 Calzetta, L; Rogliani, P; Page, C; Rinaldi, B; Cazzola, M; Matera, Mg
Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi
2017-01-01 Calzetta, L; Rogliani, P; Facciolo, F; Rendina, E; Cazzola, M; Matera, M
Pharmacological Interpretation of the Efficacy of Ensifentrine in Chronic Obstructive Pulmonary Disease: Insights from ENHANCE Trials
2024-01-15 Calzetta, L; Cazzola, M; Rogliani, P
Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation
2017-01-01 Cazzola, M; Calzetta, L; Facciolo, F; Rogliani, P; Matera, M
Pharmacological management of adult patients with acute respiratory distress syndrome
2020-01-01 Matera, Mg; Rogliani, P; Bianco, A; Cazzola, M
Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review
2020-01-01 Matera, Mg; Rogliani, P; Calzetta, L; Cazzola, M
Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure
2010-01-01 Matera, M; Martuscelli, E; Cazzola, M
Pharmacological treatment and current controversies in COPD
2019-01-01 Cazzola, M; Rogliani, P; Stolz, D; Matera, Mg
Pharmacology and therapeutics of bronchodilators
2012-06-01 Cazzola, M; Page, C; Calzetta, L; Matera, M
Pharmacology and Therapeutics of Bronchodilators Revisited
2020-01-01 Matera, Mg; Page, Cp; Calzetta, L; Rogliani, P; Cazzola, M
Pharmacology of the small airways [Farmacologia delle piccole vie aeree]
2009-01-01 Cazzola, M
Phenotypic heterogeneity influences the behavior of rat aortic smooth muscle cells in collagen lattice
2005-12-10 Orlandi, A; Ferlosio, A; Gabbiani, G; Spagnoli, Lg; Ehrlich, P
Physiologic and biological markers to assess the progression of chronic obstructive pulmonary disease [Quali parametri funzionali e biologici per la valutazione della progressione della broncopneumopatia cronica ostruttiva]
2008-01-01 Cazzola, M
Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis
2019-01-01 Vancheri, C; Sebastiani, A; Tomassetti, S; Pesci, A; Rogliani, P; Tavanti, L; Luppi, F; Harari, S; Rottoli, P; Ghirardini, A; Kirchgaessler, K-; Albera, C
Pirfenidone, nintedanib and N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
2016-01-01 Rogliani, P; Calzetta, L; Cavalli, F; Matera, M; Cazzola, M
Pleiotropic effects of hypoglycemic agents: implications in asthma and COPD
2018-01-01 Rogliani, P; Ora, J; Di Daniele, N; Lauro, D
Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: A meta-analysis
2011-11-27 Cazzola, M; Anapurapu, S; Page, C
Poor heart failure symptom response is associated with an increased risk of death and emergent healthcare utilization
2016-01-01 Vellone, E; Cocchieri, A; Paturzo, M; Riegel, B; Jaarsma, T; Stromberg, A; Alvaro, R; Lee, C
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile